Literature DB >> 10025703

Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease.

R M Marié1, L Barré, B Dupuy, F Viader, G Defer, J C Baron.   

Abstract

Indirect evidence from human and monkey investigations supports the idea that impaired frontal tasks in Parkinson's disease (PD) may result from striato-frontal disruption caused by dopamine (DA) denervation of the caudate nucleus. To directly investigate this hypothesis, we used PET with 11C-S-Nomifensine (11C-S-NMF), a sensitive marker of striatal DA denervation, in 10 non-demented PD patients in whom two frontal executive tests, the object alternation (OA) and the conditional associative learning (CAL) tasks, thought to reflect mainly set-shifting/inhibition and planning, respectively, were given. In addition, the central executive function of verbal working memory was assessed with the Brown Peterson paradigm (BPP). We found a highly significant correlation between right caudate 11C-S-NMF specific binding and OA performance, less significant and reverse-direction correlations between CAL performance and putamen 11C-S-NMF binding, and no significant correlation with BPP performance. Thus, caudate DA denervation may subtend poor set-shifting/inhibition process in PD. Our results also point to distinct and complex relationships between striatal DA and specific frontal tasks.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10025703     DOI: 10.1016/s0304-3940(98)00928-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  47 in total

1.  Sentence processing in Lewy body spectrum disorder: the role of working memory.

Authors:  Rachel G Gross; Corey T McMillan; Keerthi Chandrasekaran; Michael Dreyfuss; Sharon Ash; Brian Avants; Philip Cook; Peachie Moore; David J Libon; Andrew Siderowf; Murray Grossman
Journal:  Brain Cogn       Date:  2012-01-02       Impact factor: 2.310

2.  Difficulty processing temporary syntactic ambiguities in Lewy body spectrum disorder.

Authors:  Murray Grossman; Rachel G Gross; Peachie Moore; Michael Dreyfuss; Corey T McMillan; Philip A Cook; Sherry Ash; Andrew Siderowf
Journal:  Brain Lang       Date:  2011-09-29       Impact factor: 2.381

Review 3.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

Review 4.  Neuroimaging and cognition in Parkinson's disease dementia.

Authors:  Lisa C Silbert; Jeffrey Kaye
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

5.  Striatal dopamine influences the default mode network to affect shifting between object features.

Authors:  Linh C Dang; Aneesh Donde; Cindee Madison; James P O'Neil; William J Jagust
Journal:  J Cogn Neurosci       Date:  2012-05-29       Impact factor: 3.225

6.  Metabolic brain networks associated with cognitive function in Parkinson's disease.

Authors:  Chaorui Huang; Paul Mattis; Chengke Tang; Kenneth Perrine; Maren Carbon; David Eidelberg
Journal:  Neuroimage       Date:  2006-11-17       Impact factor: 6.556

7.  Theta burst stimulation-induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set-shifting task: a TMS-[(11)C]raclopride PET study.

Authors:  Ji H Ko; Oury Monchi; Alain Ptito; Peter Bloomfield; Sylvain Houle; Antonio P Strafella
Journal:  Eur J Neurosci       Date:  2008-11       Impact factor: 3.386

8.  Source memory and frontal functioning in Parkinson's disease.

Authors:  Lauren L Drag; Linas A Bieliauskas; Alfred W Kaszniak; Nicolaas I Bohnen; Elizabeth L Glisky
Journal:  J Int Neuropsychol Soc       Date:  2009-05       Impact factor: 2.892

Review 9.  Pathophysiology of parkinsonism.

Authors:  Adriana Galvan; Thomas Wichmann
Journal:  Clin Neurophysiol       Date:  2008-05-07       Impact factor: 3.708

Review 10.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.